The role of secreted osteoclastogenic factor of activated T cells in bone remodeling
Authors:
Open Access
- 22 July 2022
- journal article
- review article
- Published by Elsevier in Japanese Dental Science Review
- Vol. 58, 227-232
Abstract
No abstract availableKeywords
Funding Information
- Scientific Research Foundation for Returned Scholars of Ministry of Education
- Tongji Hospital
- National Natural Science Foundation of China (81300883)
- Natural Science Foundation of Hubei Province (2019CFB688, 2021CFB056)
This publication has 59 references indexed in Scilit:
- Matrix-embedded cells control osteoclast formationNature Medicine, 2011
- Processing of the NF-κB2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiationJournal of Bone and Mineral Research, 2010
- Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the hostPeriodontology 2000, 2009
- A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL‐independent mannerArthritis & Rheumatism, 2009
- Human osteoclastogenic T cells and human osteoclastologyArthritis & Rheumatism, 2009
- PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblastsBlood, 2009
- The Role of NFAT in Osteoclast FormationAnnals of the New York Academy of Sciences, 2007
- Bone RemodelingAnnals of the New York Academy of Sciences, 2006
- Cellular, molecular, and tissue-level reactions to orthodontic forceAmerican Journal of Orthodontics and Dentofacial Orthopedics, 2006
- Osteoclast differentiation and activationNature, 2003